» Articles » PMID: 12566385

Clinical and Functional Effects of a Deletion in a COOH-terminal Lumenal Loop of the Skeletal Muscle Ryanodine Receptor

Overview
Journal Hum Mol Genet
Date 2003 Feb 5
PMID 12566385
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

We have identified a patient affected by a relatively severe form of central core disease (CCD), carrying a heterozygous deletion (amino acids 4863-4869) in the pore-forming region of the sarcoplasmic reticulum calcium release channel. The functional effect of this deletion was investigated (i) in lymphoblastoid cells from the affected patient and her mother, who was also found to harbour the mutation and (ii) in HEK293 cells expressing recombinant mutant channels. Lymphoblastoid cells carrying the RYR1 deletion exhibit an 'unprompted' calcium release from intracellular stores, resulting in significantly smaller thapsigargin-sensitive intracellular Ca(2+) stores, compared with lymphoblastoid cells from control individuals. Blocking the RYR1 with dantrolene restored the intracellular calcium stores to levels similar to those found in control cells. Single channel and [(3)H]ryanodine binding measurements of heterologously expressed mutant channels revealed a reduced ion conductance and loss of ryanodine binding and regulation by Ca(2+). Heterologous expression of recombinant RYR1 peptides and analysis of their membrane topology demonstrate that the deleted amino acids are localized in the lumenal loop connecting membrane-spanning segments M8 and M10. We provide evidence that a deletion in the lumenal loop of RYR1 alters channel function and causes CCD.

Citing Articles

Dual role of the S5 segment in type 1 ryanodine receptor channel gating.

Murayama T, Otori Y, Kurebayashi N, Yamazawa T, Oyamada H, Sakurai T Commun Biol. 2024; 7(1):1108.

PMID: 39294299 PMC: 11411075. DOI: 10.1038/s42003-024-06787-1.


Preclinical model systems of ryanodine receptor 1-related myopathies and malignant hyperthermia: a comprehensive scoping review of works published 1990-2019.

Lawal T, Wires E, Terry N, Dowling J, Todd J Orphanet J Rare Dis. 2020; 15(1):113.

PMID: 32381029 PMC: 7204063. DOI: 10.1186/s13023-020-01384-x.


Variable myopathic presentation in a single family with novel skeletal RYR1 mutation.

Attali R, Aharoni S, Treves S, Rokach O, Becker Cohen M, Fellig Y PLoS One. 2013; 8(7):e69296.

PMID: 23894444 PMC: 3722152. DOI: 10.1371/journal.pone.0069296.


Calcitonin gene-related peptide restores disrupted excitation-contraction coupling in myotubes expressing central core disease mutations in RyR1.

Vega A, Ramos-Mondragon R, Calderon-Rivera A, Zarain-Herzberg A, Avila G J Physiol. 2011; 589(Pt 19):4649-69.

PMID: 21825032 PMC: 3213414. DOI: 10.1113/jphysiol.2011.210765.


Changes in negative charge at the luminal mouth of the pore alter ion handling and gating in the cardiac ryanodine-receptor.

Mead-Savery F, Wang R, Tanna-Topan B, Chen S, Welch W, Williams A Biophys J. 2009; 96(4):1374-87.

PMID: 19217855 PMC: 2717239. DOI: 10.1016/j.bpj.2008.10.054.